News
StockStory.org on MSN1h
Johnson & Johnson (NYSE:JNJ) Reports Bullish Q2, Full-Year Sales Guidance is OptimisticMultinational healthcare company Johnson & Johnson (NYSE:JNJ) in Q2 CY2025, with sales up 5.8% year on year to $23.74 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback